Vitamin D levels affect outcome in pediatric hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 10, 2014, Pages 1537-1543

  Norlin, Anna Carin ^a,b   Omazic, Brigitta ^a,b   Wikström, Ann Charlotte ^a,b   Bergman, Peter ^a,b   Winiarski, Jacek ^a,b   Remberger, Mats ^a,b   Sundin, Mikael ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

25 OH vitamin D; Bone marrow transplantation; Micronutrient

Indexed keywords

IMMUNOGLOBULIN; VITAMIN D; MYELOABLATIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AFRICAN; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; EUROPEAN; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NEWBORN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; RELAPSE; VITAMIN BLOOD LEVEL; ACUTE DISEASE; ALLOTRANSPLANTATION; BLOOD; CHRONIC DISEASE; FOLLOW UP; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL; VITAMIN D DEFICIENCY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYELOABLATIVE AGONISTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84912522599     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.05.030     Document Type: Article

References (33)

1. Khoo A.L., Chai L., Koenen H., et al. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 2012, 38:122-135.
2. Bergman P., Norlin A.C., Hansen S., et al. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2012, 2:e001663.
3. Di Rosa M., Malaguarnera M., Nicoletti F., Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 2011, 134:123-139.
4. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
5. Ginde A.A., Mansbach J.M., Camargo C.A. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 2009, 9:81-87.
6. Rosenblatt J., Bissonnette A., Ahmad R., et al. Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transplant 2010, 45:1463-1468.
7. Silva F., Perez-Simon J.A., Caballero-Velazquez T., et al. Effect of vitamin D treatment in chronic GVHD. Bone Marrow Transplant 2011, 46:1395-1397.
8. Sato T., Fukagawa M., Uchida K., et al. 1,25-Dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clin Transplant 2009, 23:368-374.
9. Duncan C.N., Vrooman L., Apfelbaum E.M., et al. 25-Hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2011, 17:749-753.
10. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. JClin Endocrinol Metab 2011, 96:53-58.
11. Remberger M., Ackefors M., Berglund S., et al. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant 2011, 17:1688-1697.
12. Sundin M., Nordin K., Jostemyr Y., Winiarski J. Subcutaneous IgG replacement after pediatric SCT. Pediatr Transplant 2012, 16:866-871.
13. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
14. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease. I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005, 11:945-956.
15. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
16. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data 2002, John Wiley & Sons, Hoboken, NJ.
17. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
18. Hodler B., Evequoz V., Trechsel U., et al. Influence of vitamin D3 metabolites on the production of interleukins 1, 2 and 3. Immunobiology 1985, 170:256-269.
19. Schwalfenberg G.K. Areview of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011, 55:96-108.
20. Holick M.F. The D-lightful vitamin D for child health. JParenter Enteral Nutr 2012, 36:9S-19S.
21. van Schoor N.M., Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011, 25:671-680.
22. Rajakumar K., Holick M.F., Jeong K., et al. Impact of season and diet on vitamin D status of African American and Caucasian children. Clin Pediatr 2011, 50:493-502.
23. Joseph R.W., Alousi A., Konda B., et al. High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation. Am J Hematol 2011, 86:954-956.
24. Urbain P., Ihorst G., Biesalski H.K., Bertz H. Course of serum 25-hydroxyvitamin D(3) status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Ann Hematol 2012, 91:759-766.
25. Robien K., Strayer L.G., Majhail N., et al. Vitamin D status among long-term survivors of hematopoietic cell transplantation. Bone Marrow Transplant 2011, 46:1472-1479.
26. El-Hajj Fuleihan G., Muwakkit S., Arabi A., et al. Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int 2012, 23:665-674.
27. Sproat L., Bolwell B., Rybicki L., et al. Vitamin D level after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2011, 17:1079-1083.
28. Simmons J.H., Chow E.J., Koehler E., et al. Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant. Pediatr Blood Cancer 2011, 56:1114-1119.
29. Pakkala I., Taskinen E., Pakkala S., Raisanen-Sokolowski A. MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation. Bone Marrow Transplant 2001, 27:863-867.
30. Vanham G., Van Baelen H., Tan B.K., Bouillon R. The effect of vitamin D analogs and of vitamin D-binding protein on lymphocyte proliferation. JSteroid Biochem 1988, 29:381-386.
31. Ferreira G.B., Overbergh L., Verstuyf A., Mathieu C. 1Alpha,25-Dihydroxyvitamin D(3) and its analogs as modulators of human dendritic cells: a comparison dose-titration study. JSteroid Biochem Mol Biol 2013, 136:160-165.
32. Glotzbecker B., Ho V.T., Aldridge J., et al. Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD. Bone Marrow Transplant 2013, 48:593-597.
33. Wang T.T., Nestel F.P., Bourdeau V., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. JImmunol 2004, 173:2909-2912.